Table 2.
Effect of demographic variables, gestational age, preventive measures, prophylaxis and clinical symptoms on mean parasite densities (MPD±SD) in pregnant women (n=270).
| Variables | n | MPD±SD | P-value | |
|---|---|---|---|---|
| Age group (years) | 15-20 | 15 | 6053 ± 7664 | |
| 21-26 | 40 | 4291 ± 2436 | ||
| 27-32 | 40 | 3814 ± 3089 | ||
| 33-38 | 17 | 4078 ±1396 | ||
| >38 | 4 | 2419 ±1396 | ||
| Total | 115 | 0.33 | ||
| Gestation age (months) | 1-3 | 40 | 4463 ± 3162 | |
| 4-6 | 47 | 4283 ± 4827 | ||
| 7-9 | 28 | 3861 ± 2594 | ||
| Total | 115 | 0.81 | ||
| Education | Primary | 15 | 3517 ± 2490 | |
| Secondary | 57 | 5068 ± 5068 | ||
| Tertiary | 43 | 3402 ± 2286 | ||
| Total | 115 | 0.68 | ||
| Vector control measures | Window/door screens | 22 | 4508 ± 4579 | |
| Treated nets | 40 | 4314 ± 4474 | ||
| Untreated nets | 9 | 5617 ± 3221 | ||
| Insecticides | 32 | 4082 ± 2853 | ||
| Insecticides and others | 3 | 4152 ± 2749 | ||
| No Protection | 6 | 2501 ± 2270 | ||
| Total | 112 | 0.77 | ||
| Antimalaria drug use | AL* | 15 | 3427 ± 1871 | |
| Quinine | 11 | 5353 ± 5626 | ||
| SP** | 55 | 4212 ± 2893 | ||
| None | 17 | 6342 ± 6269 | ||
| Total | 98 | 0.14 | ||
| Clinical symptoms | Asymptomatic | 15 | 1847 ± 1318 | |
| Headache | 16 | 3764 ± 1949 | ||
| Headache and Fever | 73 | 4931 ± 4301 | ||
| Fever | 11 | 3644 ± 3284 | ||
| Total | 115 | 0.03 |
* AL: Artemether-lumefantrine; ** SP: Sulphadoxine- pyrimethamine